Physician profile
Rohit Gupta
NPI 1821225863
$10,475.36
in general payments reported to CMS, 2019-2025
15 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $58.32 · 2021: $2,957 · 2022: $1,807 · 2023: $5,084 · 2024: $51.19 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,950 · Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,950.00 |
| Food and Beverage | $332.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $9,443.85 | 2019-2023 | |
| Abbvie INC. | $367.25 | 2019-2021 | |
| Amgen INC. | $111.93 | 2025 | Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $96.36 | 2020-2024 | Eohilia |
| Travere Therapeutics, INC. | $80.10 | 2019-2023 | Cholbam |
| Genzyme Corporation | $59.40 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $55.49 | 2022-2023 | Dupixent |
| Phadia US INC. | $51.40 | 2021-2022 | |
| Alcresta Therapeutics, INC. | $45.34 | 2023 | Relizorb |
| Mirum Pharmaceuticals, INC. | $36.51 | 2023-2024 | Livmarli |
| Pfizer INC. | $36.50 | 2021 | |
| Janssen Biotech, INC. | $28.17 | 2022 | |
| Shire North American Group INC | $24.65 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.97 | 2023 | |
| Nestle Healthcare Nutrition INC. | $18.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.